These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3571941)

  • 21. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.
    Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L
    Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Nithsdale Schizophrenia survey: II. Abnormal movements.
    McCreadie RG; Barron ET; Winslow GS
    Br J Psychiatry; 1982 Jun; 140():587-90. PubMed ID: 6125227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
    Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
    Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of tardive dyskinesia and pseudoparkinsonism.
    Yassa R; Nair V
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):909-14. PubMed ID: 3241874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-induced tardive syndrome: a retrospective epidemiological study.
    Lee Y; Lin PY; Chang YY; Chong MY; Cheng AT
    Pharmacopsychiatry; 2013 Nov; 46(7):281-5. PubMed ID: 24057776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of tardive dyskinesia in psychiatric inpatients in Japan.
    Koshino Y; Madokoro S; Ito T; Horie T; Mukai M; Isaki K
    Clin Neuropharmacol; 1992 Feb; 15(1):34-43. PubMed ID: 1349507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
    Farber RH; Stull DE; Witherspoon B; Evans CJ; Yonan C; Bron M; Dhanda R; Jen E; Brien CO'
    J Patient Rep Outcomes; 2024 Jan; 8(1):2. PubMed ID: 38175450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.
    Schulze TG; Schumacher J; Müller DJ; Krauss H; Alfter D; Maroldt A; Ahle G; Maroldt AO; Novo y Fernández A; Weber T; Held T; Propping P; Maier W; Nöthen MM; Rietschel M
    Am J Med Genet; 2001 Aug; 105(6):498-501. PubMed ID: 11496364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.
    Huang Y; Pan L; Teng F; Wang G; Li C; Jin L
    Shanghai Arch Psychiatry; 2017 Oct; 29(5):295-303. PubMed ID: 29276353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a six-week drug holiday on symptom status, relapse, and tardive dyskinesia in chronic schizophrenics.
    Shenoy RS; Sadler AG; Goldberg SC; Hamer RM; Ross B
    J Clin Psychopharmacol; 1981 May; 1(3):141-5. PubMed ID: 6117584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Historical perspective on movement disorders.
    Friedman JH
    J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of complaints in schizophrenics with tardive dyskinesia.
    Alexopoulos GS
    J Nerv Ment Dis; 1979 Feb; 167(2):125-7. PubMed ID: 33230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
    Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
    Go CL; Rosales RL; Caraos RJ; Fernandez HH
    Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.